Home›People›Jerry Leamon
JL

Jerry Leamon

Director at Cytogel Pharma.

Director
Updated Nov 10, 2026·Latest SEC filing Mar 26, 2026·Suggest an edit

About Jerry Leamon

Jerry Leamon is a director at Cytogel Pharma.

Jerry Leamon first appears on SEC filings in 2023.

Experience

This experience comes from Jerry Leamon's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jerry Leamon in the role, so the role may have started earlier or lasted longer.

CBTS Current
Board Member
2024 – Present
Cytogel Pharma, LLC Current
Director
2023 – Present · Darien, CT
Develops investigational medicines for people with moderate to severe pain.
Jackson Hewitt Tax Service Inc. Current
Board Member
2019 – Present
Korn Ferry Current
Board Member
2012 – Present
Geller & Company Current
Vice Chairman, Advisory Board
2012 – Present
University of Cincinnati Current
Member, Foundation Board; Lindner College of Business Advisory Board; University Advisors
2004 – Present
Credit Suisse
Member Board Of Directors, Credit Suisse USA
2016 – 2024
AmeriCares
Chairman Of The Board Of Directors
2006 – 2022
G3 (Good Governance Group)
Advisor and Member of Global Business Council
2012 – 2016
Deloitte & Touche
Partner
1981 – 2012

Key Colleagues at Startups

The people Jerry Leamon works with at each company, as listed on that company's latest Form D.

Cytogel Pharma, LLC · Form D/A, Mar 26, 2026
C. Maglaris
C. Maglaris
CEO & Chair of Board of Managers
MU
Theodore Maione
Theodore Maione
Chief Scientific Officer
SC
Steven Chrust
Outside and director
EL
Eric Lang
Director
FT
Frederick Telling
Outside and director
CK
Cassandra Klimp
Non-executive Director

Sources

  1. SECCytogel Pharma, LLC Form D/A, filed Mar 26, 2026